LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 260

Search options

  1. Article ; Online: Ongoing Measles in the Developed and Developing World.

    Cherry, James D

    Journal of the Pediatric Infectious Diseases Society

    2024  Volume 13, Issue 4, Page(s) 233–236

    Abstract: Measles is a vaccine-preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, ... ...

    Abstract Measles is a vaccine-preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, measles is associated with a number of complications which can be places in three categories which are: acute(diarrhea, otitis media, pneumonia, encephalitis, seizures, and death) and delayed-subacute sclerosing panencephalitis (SSPE) and post-measles immune amnesia. Contrary to the beliefs of the anti-vaccine lobby, measles is bad. In acute measles, the death rate is 1-3 per 1000 and the risk of encephalitis is 1 per 1000. Relatively recent investigations indicate that SSPE is considerably more common than previously believed. The worldwide contribution of post-measles immune amnesia to morbidity and mortality is likely to be huge. In exposure situations, two doses of measles vaccine will prevent 99% of cases. Presently in the United States, the first dose is given at 12 through 15 months of age. The second dose is most often administered at 4 through 6 years of age. In my opinion, the second dose of measles vaccine should be given 4-6 weeks after the first dose rather than at 4-6 years of age. Children who don't have antibody to measles should not travel to risk areas.
    MeSH term(s) Humans ; Measles/prevention & control ; Measles/epidemiology ; Measles Vaccine/administration & dosage ; Developing Countries ; Developed Countries ; Child ; Subacute Sclerosing Panencephalitis/prevention & control ; Subacute Sclerosing Panencephalitis/immunology ; Infant ; Child, Preschool ; Immunization Schedule ; Vaccination
    Chemical Substances Measles Vaccine
    Language English
    Publishing date 2024-02-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piae018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book: Feigin and Cherry's textbook of pediatric infectious diseases / 1

    Feigin, Ralph D. / Cherry, James D.

    2014  

    Author's details James D. Cherry
    Collection Feigin and Cherry's textbook of pediatric infectious diseases
    Language English
    Size XXXVII, 1834, I95 S. : Ill., graph. Darst.
    Publisher Elsevier Saunders
    Publishing place Philadelphia, Pa
    Publishing country United States
    Document type Book
    Accompanying material Zugang zur Internetausgabe über Code
    HBZ-ID HT018093369
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Book: Feigin and Cherry's textbook of pediatric infectious diseases / 2

    Feigin, Ralph D. / Cherry, James D.

    2014  

    Author's details James D. Cherry
    Collection Feigin and Cherry's textbook of pediatric infectious diseases
    Language English
    Size XXXVII S., S. 1836 - 3627, I95 S. : Ill., graph. Darst.
    Publisher Elsevier Saunders
    Publishing place Philadelphia, Pa
    Publishing country United States
    Document type Book
    HBZ-ID HT018093436
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Book ; Collection: Feigin and Cherry's textbook of pediatric infectious diseases

    Feigin, Ralph D. / Cherry, James D.

    (ExpertConsult.com)

    2014  

    Title variant Feigin & Cherry's textbook of pediatric infectious diseases ; Textbook of pediatric infectious diseases
    Author's details James D. Cherry
    Series title ExpertConsult.com
    Keywords Communicable Diseases ; Child ; Pediatrics / methods
    Language English
    Dates of publication 2014-9999
    Edition 7. ed.
    Publisher Elsevier Saunders
    Publishing place Philadelphia, Pa
    Publishing country United States
    Document type Book ; Collection (display volumes)
    Note Includes bibliographical references and index
    HBZ-ID HT018093355
    ISBN 978-1-4557-1177-2 ; 1-4557-1177-2
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article ; Online: The Role of Face Protection for Respiratory Viral Infections: A Historical Perspective.

    Cherry, James D

    Journal of the Pediatric Infectious Diseases Society

    2020  Volume 9, Issue 4, Page(s) 411–412

    MeSH term(s) Aerosols ; COVID-19 ; Coronavirus Infections/history ; Coronavirus Infections/prevention & control ; Coronavirus Infections/transmission ; Coronavirus Infections/virology ; Eye Protective Devices/history ; Female ; History, 19th Century ; History, 20th Century ; History, 21st Century ; Humans ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Male ; Masks/history ; Pandemics/history ; Pandemics/prevention & control ; Pneumonia, Viral/history ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/transmission ; Pneumonia, Viral/virology ; Respiratory Tract Infections/history ; Respiratory Tract Infections/prevention & control ; Respiratory Tract Infections/transmission ; Respiratory Tract Infections/virology
    Chemical Substances Aerosols
    Keywords covid19
    Language English
    Publishing date 2020-08-02
    Publishing country England
    Document type Historical Article ; Journal Article
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piaa082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Pertussis vaccines.

    Cherry, James D / Doustmohammadi, Saba

    Current opinion in pediatrics

    2022  Volume 34, Issue 2, Page(s) 126–131

    Abstract: Purpose of review: Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination.: Recent findings: Pertussis cases and deaths in children are at a record low number. More complete use of adolescent/adult ... ...

    Abstract Purpose of review: Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination.
    Recent findings: Pertussis cases and deaths in children are at a record low number. More complete use of adolescent/adult vaccine can further reduce morbidity and mortality.
    Summary: Considerable progress in the control of pertussis has occurred over the last 75 years. The universal use of Tdap vaccines in all pregnant women will prevent virtually all pertussis deaths.
    MeSH term(s) Adolescent ; Adult ; Child ; Diphtheria-Tetanus-acellular Pertussis Vaccines ; Female ; Humans ; Pregnancy ; Pregnant Women ; Vaccination ; Whooping Cough/epidemiology ; Whooping Cough/prevention & control
    Chemical Substances Diphtheria-Tetanus-acellular Pertussis Vaccines
    Language English
    Publishing date 2022-01-27
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1049374-8
    ISSN 1531-698X ; 1040-8703
    ISSN (online) 1531-698X
    ISSN 1040-8703
    DOI 10.1097/MOP.0000000000001108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Feigin & Cherry's textbook of pediatric infectious diseases / 2

    Feigin, Ralph D. / Cherry, James D.

    2009  

    Author's details Ralph D. Feigin ; James D. Cherry
    Collection Feigin & Cherry's textbook of pediatric infectious diseases
    Language English
    Size XXXIX S., S. 1725 - 3567, XCIV S. : Ill., graph. Darst., Kt.
    Publisher Saunders Elsevier
    Publishing place Philadelphia, Pa
    Publishing country United States
    Document type Book
    HBZ-ID HT016093979
    ISBN 978-1-4160-4044-6 ; 1-4160-4044-7
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Book: Feigin & Cherry's textbook of pediatric infectious diseases / 1

    Feigin, Ralph D. / Cherry, James D.

    2009  

    Author's details Ralph D. Feigin ; James D. Cherry
    Collection Feigin & Cherry's textbook of pediatric infectious diseases
    Language English
    Size XXXIX, 1724, XCIV S. : Ill., graph. Darst., Kt.
    Publisher Saunders Elsevier
    Publishing place Philadelphia, Pa
    Publishing country United States
    Document type Book
    Accompanying material Zugang zur Internetausgabe über Code
    HBZ-ID HT016093955
    ISBN 978-1-4160-4044-6 ; 1-4160-4044-7
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  9. Article ; Online: The prevention of severe pertussis and pertussis deaths in young infants.

    Cherry, James D

    Expert review of vaccines

    2019  Volume 18, Issue 3, Page(s) 205–208

    Abstract: Introduction: Today, in the developed world, virtually all deaths due to Bordetella pertussis illnesses occur in young infants. Areas Covered: Pertussis in young infants is characterized by an afebrile cough illness with coryza, apnea, seizures, ... ...

    Abstract Introduction: Today, in the developed world, virtually all deaths due to Bordetella pertussis illnesses occur in young infants. Areas Covered: Pertussis in young infants is characterized by an afebrile cough illness with coryza, apnea, seizures, cyanosis, and emesis. Severe illness is associated with high leukocyte and lymphocyte counts, rapid respiratory and cardiac rates and pneumonia. Many routine intensive care treatment procedures are detrimental: these include steroids and nitric oxide. Preventative measures include: quarantine, prophylactic antimicrobial agents and immunizations of the mother to be with Tdap between 27 and 36 weeks gestation. Expert Opinion: Infants deaths are due to the irreversible pulmonary hypertension which is caused by aggregates of leukocytes in the small vessels in the lung. The leukocytosis with lymphocytosis is due to pertussis toxin. It can be treated by exchange blood transfusions. However for this to be successful it needs to be started before shock or organ failure has occurred. To prevent pertussis in young infants, attention needs to be directed to the diagnosis and treatment of pertussis in adolescents and adults. Also important are antimicrobial prophylaxis in the infant and the immunization of mothers to be with Tdap vaccine during all pregnancies.
    MeSH term(s) Adolescent ; Adult ; Bordetella pertussis/isolation & purification ; Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage ; Female ; Humans ; Infant ; Pregnancy ; Vaccination/methods ; Whooping Cough/mortality ; Whooping Cough/physiopathology ; Whooping Cough/prevention & control
    Chemical Substances Diphtheria-Tetanus-acellular Pertussis Vaccines
    Language English
    Publishing date 2019-02-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2181284-6
    ISSN 1744-8395 ; 1476-0584
    ISSN (online) 1744-8395
    ISSN 1476-0584
    DOI 10.1080/14760584.2019.1581065
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future.

    Cherry, James D

    Journal of the Pediatric Infectious Diseases Society

    2019  Volume 8, Issue 4, Page(s) 334–341

    Abstract: Effective diphtheria, tetanus toxoids, whole-cell pertussis (DTwP) vaccines became available in the 1930s, and they were put into routine use in the United States in the 1940s. Their use reduced the average rate of reported pertussis cases from 157 in ... ...

    Abstract Effective diphtheria, tetanus toxoids, whole-cell pertussis (DTwP) vaccines became available in the 1930s, and they were put into routine use in the United States in the 1940s. Their use reduced the average rate of reported pertussis cases from 157 in 100 000 in the prevaccine era to <1 in 100 000 in the 1970s. Because of alleged reactions (encephalopathy and death), several countries discontinued (Sweden) or markedly decreased (United Kingdom, Germany, Japan) use of the vaccine. During the 20th century, Bordetella pertussis was studied extensively in animal model systems, and many "toxins" and protective antigens were described. A leader in B pertussis research was Margaret Pittman of the National Institutes of Health/US Food and Drug Administration. She published 2 articles suggesting that pertussis was a pertussis toxin (PT)-mediated disease. Dr Pittman's views led to the idea that less-reactogenic acellular vaccines could be produced. The first diphtheria, tetanus, pertussis (DTaP) vaccines were developed in Japan and put into routine use there. Afterward, DTaP vaccines were developed in the Western world, and definitive efficacy trials were carried out in the 1990s. These vaccines were all less reactogenic than DTwP vaccines, and despite the fact that their efficacy was less than that of DTwP vaccines, they were approved in the United States and many other countries. DTaP vaccines replaced DTwP vaccines in the United States in 1997. In the last 13 years, major pertussis epidemics have occurred in the United States, and numerous studies have shown the deficiencies of DTaP vaccines, including the small number of antigens that the vaccines contain and the type of cellular immune response that they elicit. The type of cellular response a predominantly, T2 response results in less efficacy and shorter duration of protection. Because of the small number of antigens (3-5 in DTaP vaccines vs >3000 in DTwP vaccines), linked-epitope suppression occurs. Because of linked-epitope suppression, all children who were primed by DTaP vaccines will be more susceptible to pertussis throughout their lifetimes, and there is no easy way to decrease this increased lifetime susceptibility.
    MeSH term(s) Antibodies, Bacterial ; Antigens, Bacterial ; Bordetella pertussis/immunology ; Diphtheria-Tetanus-Pertussis Vaccine/immunology ; Germany ; Humans ; Immunity ; Japan ; Pertussis Toxin/immunology ; Pertussis Vaccine/adverse effects ; Pertussis Vaccine/immunology ; Sweden ; Time Factors ; United Kingdom ; United States/epidemiology ; Whooping Cough/epidemiology ; Whooping Cough/prevention & control
    Chemical Substances Antibodies, Bacterial ; Antigens, Bacterial ; Diphtheria-Tetanus-Pertussis Vaccine ; Pertussis Vaccine ; Pertussis Toxin (EC 2.4.2.31)
    Language English
    Publishing date 2019-02-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2668791-4
    ISSN 2048-7207 ; 2048-7193
    ISSN (online) 2048-7207
    ISSN 2048-7193
    DOI 10.1093/jpids/piz005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top